NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form?prid=108603&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) […]

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sage-therapeutics-lawsuit-submission-form?prid=108610&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of VinFast Auto Ltd. ("VinFast" or the "Company") (NASDAQ:VFS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether VinFast and certain of its officers and/or directors have

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Toronto-Dominion Bank ("The Toronto-Dominion Bank") (NYSE:TD) concerning possible violations of federal securities laws. On October 10, 2024, TD Bank issued a press release announcing the resolution of the AML investigations into the

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Kaspi and certain of its officers and/or directors

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ:RVNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Revance and certain of its officers and/or directors have

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=108596&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Spire Global, Inc. (NYSE:SPIR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/spire-global-inc-lawsuit-submission-form?prid=108595&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ:ADMA) concerning possible violations of federal securities laws. On October 9, 2024, ADMA Biologics disclosed the surprise resignation of its independent outside auditor CohnReznick LLP. The news

Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records. Record Export Wholesale Revenue1: Generated $5.1 million in Q3 2024 representing a 116% increase over Q3 2023, establishing a new company record. Record Cannabis Production: 3,441 kilograms produced in Q3 2024, representing a